Clinical Trial Update: Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating iberdomide (CC-220) as maintenance therapy after autologous stem cell transplant in newly diagnosed multiple myeloma patients; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Iberdomide (Cc220) (iberdomide)

Snippet

Sponsor: Stichting European Myeloma Network | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING